Hans Kasper Binz

Title: The Innovations of Hans Kasper Binz

Introduction

Hans Kasper Binz is a notable inventor based in Birmensdorf, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins. With a total of two patents to his name, his work focuses on innovative solutions for medical applications.

Latest Patents

One of Hans Kasper Binz's latest patents involves binding proteins that inhibit the VEGF-A receptor interaction. This invention relates to recombinant binding proteins that specifically target VEGF-A, particularly those that inhibit its binding to the VEGFR-2 receptor. These binding proteins have potential applications in treating cancer and other pathological conditions, including eye diseases such as age-related macular degeneration. His second patent describes collections of repeat proteins, each comprising a repeat domain made up of consecutive repeat modules. These proteins differ from others in the collection by at least one amino acid position, contributing to their unique interactions with target substances.

Career Highlights

Throughout his career, Hans Kasper Binz has worked with prominent organizations, including Molecular Partners AG and the University of Zurich. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Hans has collaborated with notable colleagues such as Patrik Forrer and Michael Tobias Stumpp. Their combined expertise has furthered the development of innovative solutions in biotechnology.

Conclusion

Hans Kasper Binz's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and applications.